- Home
- BFRI vs DRCT Comparison
BFRI vs DRCT Comparison
Compare BFRI & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- DRCT
- Stock Information
- Founded
- BFRI 1997
- DRCT 2018
- Country
- BFRI United States
- DRCT United States
- Employees
- BFRI N/A
- DRCT N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- DRCT Computer Software: Programming Data Processing
- Sector
- BFRI Health Care
- DRCT Technology
- Exchange
- BFRI Nasdaq
- DRCT Nasdaq
- Market Cap
- BFRI 7.9M
- DRCT 9.2M
- IPO Year
- BFRI 2021
- DRCT 2022
- Fundamental
- Price
- BFRI $0.84
- DRCT $0.44
- Analyst Decision
- BFRI Strong Buy
- DRCT Strong Buy
- Analyst Count
- BFRI 1
- DRCT 1
- Target Price
- BFRI $2.75
- DRCT $6.00
- AVG Volume (30 Days)
- BFRI 347.9K
- DRCT 273.3K
- Earning Date
- BFRI 08-13-2025
- DRCT 08-05-2025
- Dividend Yield
- BFRI N/A
- DRCT N/A
- EPS Growth
- BFRI N/A
- DRCT N/A
- EPS
- BFRI N/A
- DRCT N/A
- Revenue
- BFRI $39,188,000.00
- DRCT $36,459,000.00
- Revenue This Year
- BFRI $11.07
- DRCT $16.81
- Revenue Next Year
- BFRI $11.20
- DRCT $62.96
- P/E Ratio
- BFRI N/A
- DRCT N/A
- Revenue Growth
- BFRI 11.20
- DRCT N/A
- 52 Week Low
- BFRI $0.54
- DRCT $0.38
- 52 Week High
- BFRI $2.22
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- BFRI 42.93
- DRCT 44.09
- Support Level
- BFRI $0.82
- DRCT $0.43
- Resistance Level
- BFRI $0.95
- DRCT $0.49
- Average True Range (ATR)
- BFRI 0.07
- DRCT 0.03
- MACD
- BFRI -0.01
- DRCT 0.01
- Stochastic Oscillator
- BFRI 20.70
- DRCT 49.70
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.